Tyra Biosciences (TYRA) Total Liabilities (2020 - 2026)

Tyra Biosciences' Total Liabilities history runs 7 years deep, the most recent figure standing at $24.5 million for Q1 2026.

• Quarterly Total Liabilities rose 22.68% year-over-year to $24.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.5 million (up 22.68% YoY) and the FY2025 annual result came in at $23.4 million, up 14.82% from the prior year.
• Total Liabilities was $24.5 million for Q1 2026 at Tyra Biosciences, up from $23.4 million in the prior quarter.
• Across five years, Total Liabilities topped out at $24.5 million in Q1 2026 and bottomed at $6.3 million in Q1 2023.
• A 5-year average of $15.7 million and a median of $16.4 million in 2024 frame the typical range for Total Liabilities.
• Peak annual rise in Total Liabilities reached 158.56% in 2023, while the deepest fall reached 19.55% in 2023.
• Tyra Biosciences' Total Liabilities stood at $8.4 million in 2022, then jumped by 158.56% to $21.6 million in 2023, then dropped by 5.5% to $20.4 million in 2024, then rose by 14.82% to $23.4 million in 2025, then gained by 4.41% to $24.5 million in 2026.
• Business Quant data shows TYRA's Total Liabilities at $24.5 million in Q1 2026, $23.4 million in Q4 2025, and $21.3 million in Q3 2025.